Your session is about to expire
← Back to Search
Other
DTC Hearing Aids for Hearing Loss
N/A
Waitlist Available
Led By Pamela Souza, PhD
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up task will be completed at second 1 day study visit
Awards & highlights
Study Summary
This trial aims to find out if accessible hearing aids could reduce listening effort, offering a more affordable option for people with hearing loss.
Who is the study for?
This trial is for English-speaking adults with mild to moderate sensorineural or mixed hearing loss in both ears, who have at least a Grade 10 education and can bring a communication partner to the first visit. They must not currently use hearing aids regularly, have significant vision impairments, unstable medical conditions, cognitive impairments like dementia, major psychiatric disorders, or be part of other similar studies.Check my eligibility
What is being tested?
The study tests if direct-to-consumer (DTC) hearing aids programmed for individual's specific hearing losses can reduce the effort needed to listen effectively. It aims to see if these affordable DTC aids do more than just make sounds louder and could help overcome barriers preventing people from using traditional hearing aids.See study design
What are the potential side effects?
Since this trial involves non-invasive DTC hearing aids designed for personal use without professional fitting, side effects are minimal but may include discomfort wearing the device or dissatisfaction with sound amplification.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ task will be completed at second 1 day study visit
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~task will be completed at second 1 day study visit
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Diapix Conversation Task
Secondary outcome measures
Pupillometry and Recall Repeat Task (RRT)
Trial Design
1Treatment groups
Experimental Treatment
Group I: DTC Hearing AidExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
Northwestern UniversityLead Sponsor
1,601 Previous Clinical Trials
915,634 Total Patients Enrolled
16 Trials studying Hearing Loss
2,006 Patients Enrolled for Hearing Loss
Pamela Souza, PhDPrincipal InvestigatorNorthwestern University
2 Previous Clinical Trials
72 Total Patients Enrolled
2 Trials studying Hearing Loss
72 Patients Enrolled for Hearing Loss
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You wear a hearing aid for at least 4 hours a day on most days in the past year.You recently got a new hearing aid within the last 30 days.You can see well enough to do the tasks required for the study.You have ongoing trouble communicating due to a previous stroke, brain tumor, developmental disorder like Down's syndrome, or head/neck cancer.You have been diagnosed with memory or thinking problems.You have a history of severe mental illness like schizophrenia or untreated depression.You are taking part in other studies that focus on improving hearing, language, or communication.You have a history of hearing loss that comes and goes.You have been diagnosed with hearing loss caused by a problem in the ear's ability to conduct sound.You have mild to moderate hearing loss in both ears.You must pass a test to check your memory and thinking skills.
Research Study Groups:
This trial has the following groups:- Group 1: DTC Hearing Aid
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger